Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2005; 11(42): 6671-6675
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6671
Table 1 Selected clinical and laboratory parameters of patients with celiac disease and control subjects (means ± SE)
Celiac disease patientsControls
n = 33n = 35
Females/males24/913 / 22
at diagnosisin current study
Age (yrs)27.4 ± 3.032.2 ± 2.531.0 ± 1.9
Iron (μmol/L)13.0 ± 1.5a17.6±1.3c23.1 ± 2.1
Hb (g/dL)12.6 ± 0.4a13.9±0.3c15.8 ± 0.5
MCV (fL)85.5 ± 1.7a88.4±1.0c94.3 ± 2.7
RDW (%)15.7 ± 0.614.4±0.413.9 ± 0.5
BMI (kg/m2)20.0 ± 0.7 a22.8±0.623.1 ± 1.1
Table 2 Plasma carnitine ester profiles in celiac disease patients and controls (mean±SE, μmol/L)
PatientsControls
n = 33n = 35
Free carnitine (C0)27.191 ± 1.19430.029 ± 1.902
Short-chain acylcarnitines
Acetylcarnitine (C2)4.703 ± 0.205b10.227 ± 0.368
Propionylcarnitine (C3)0.247 ± 0.014b0.400 ± 0.021
Butyrylcarnitine (C4)0.152 ± 0.011b0.267 ± 0.013
Isovalerylcarnitine (C5)0.111 ± 0.0100.138 ± 0.010
Tiglylcarnitine (C5:1)0.034 ± 0.0020.033 ± 0.003
Medium-chain acylcarnitines
Hexanoylcarnitine (C6)0.060 ± 0.004b0.080 ± 0.006
Octanoylcarnitine (C8)0.086 ± 0.006b0.121 ± 0.009
Octenoylcarnitine (C8:1)0.037 ± 0.003b0.071 ± 0.008
Decanoylcarnitine (C10)0.103 ± 0.008b0.141 ± 0.009
Cecenoylcarnitine (C10:1)0.063 ± 0.005b0.108 ± 0.010
Lauroylcarnitine (C12)0.032 ± 0.002b0.052 ± 0.004
Long-chain acylcarnitines
Myristoylcarnitine (C14)0.016 ± 0.001b0.024 ± 0.001
Myristoleylcarnitine (C14:1)0.025 ± 0.002b0.040 ± 0.004
Palmitoylcarnitine (C16)0.097 ± 0.0060.113 ± 0.006
Palmitoleylcarnitine (C16:1)0.037 ± 0.0030.032 ± 0.002
Stearoylcarnitine (C18)0.076 ± 0.0040.080 ± 0.004
Oleylcarnitine (C18:1)0.137 ± 0.007b0.169 ± 0.008
Hydroxymyristoylcarnitine (C14OH)0.007 ± 0.0010.005 ± 0.001
Hydroxypalmitoylcarnitine (C16OH)0.022 ± 0.0010.023 ± 0.002
Hydroxypalmitoleylcarnitine (C16:1OH)0.026 ± 0.0020.029 ± 0.002
Hydroxyoleylcarnitine (C18:1OH)0.016 ± 0.0020.013 ± 0.002